Patent · US Active

Treatment of metastatic breast cancer

US8658172B2 · kind B2 · utility

2Cited by

2References

6Claims

0Family size

Assignee

AMGEN RESEARCH (MUNICH) GMBH · DE

Inventors

Carsten Reinhardt · Birkenfeld, DE
Robert Saller · Egglkofen, DE

Key dates

Filing date	Dec 19, 2012
Grant date	Feb 25, 2014
Priority date	—
Expiry date	Dec 19, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of an anti-EpCAM antibody for the manufacture of a medicament for the treatment of metastatic breast cancer. The present invention further relates to a method of treating metastatic breast cancer comprising administering said anti-EpCAM antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.